Naturally Occurring Alkaloids, Derivatives, and Semi-synthetic Modifications as Lead Compounds for the Development of New Anti-Trypanosoma cruzi Agents-Reference-Cited by-同舟云学术

Naturally Occurring Alkaloids, Derivatives, and Semi-synthetic Modifications as Lead Compounds for the Development of New Anti-Trypanosoma cruzi Agents

Published:2021-03-04 Issue:2 Volume:8 Page:68-86
ISSN:2196-5471
Container-title:Current Clinical Microbiology Reports
language:en
Short-container-title:Curr Clin Micro Rpt

Author:

Fernández Lucía Raquel^ORCID,Musikant Daniel^ORCID,Edreira Martin M.^ORCID

Funder

Agencia Nacional de Promoción Científica y Tecnológica

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40588-021-00163-x.pdf

Reference66 articles.

1. de Moraes J, Geary TG. FDA-approved antiparasitic drugs in the 21st century: a success for helminthiasis? Trends Parasitol England. 2020;36:573–5.

2. Pollastri MP. Fexinidazole: a new drug for African sleeping sickness on the horizon. Trends Parasitol. 2018;34:178–9.

3. Deeks ED. Fexinidazole: first global approval. Drugs; New Zealand. 2019;79:215–20.

4. Morillo CA, Waskin H, Sosa-Estani S, del Carmen BM, Cuneo C, Milesi R, et al. Benznidazole and posaconazole in eliminating parasites in asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial. J Am Coll Cardiol. 2017;69:939–47.

5. •• Urbina JA. Etiologic treatment of Chagas Disease: old drugs, new insights, challenges, and perspectives. Chagas Dis. Springer International Publishing; 2020. p. 123–44. This work extensively describes the state of the art of the most recent clinical trials against Chagas Disease and its outcomes and provides very interesting insights.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semisynthesis of alkaloids;Semisynthesis of Bioactive Compounds and their Biological Activities;2024

2. New trends in the practical use of isoquinoline alkaloids as potential drugs applicated in infectious and non-infectious diseases;Biomedicine & Pharmacotherapy;2023-12